Clinical trial
To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical…
NCT00489229 · Universiti Sains Malaysia, Other · Completed
Key facts
| NCT number | NCT00489229 |
|---|---|
| Title | To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients |
| Official title | Studies on Diabetic and Pre Diabetic Vascular Disease and the Effect of Selected Therapeutic Modalities on Associated Vasculopathy |
| Lead sponsor | Universiti Sains Malaysia, Other |
| Collaborators | Ministry of Health, Malaysia |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Impaired Glucose Tolerance |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Ramipril |
| Enrollment | 66 |
| Start date | Oct 1, 2002 |
| Completion | Dec 1, 2005 |
| First posted | Jun 21, 2007 |
| Last update posted | Jul 16, 2009 |
| Countries | Malaysia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: